VIVS (VivoSim Labs, Inc. Common Stock) Stock Analysis - SEC Filings

VivoSim Labs, Inc. Common Stock (VIVS) is a publicly traded Healthcare sector company. As of May 21, 2026, VIVS trades at $1.29 with a market cap of $3.68M and a P/E ratio of 0.00. VIVS moved +0.00% today. Year to date, VIVS is -33.33%; over the trailing twelve months it is -35.96%. Its 52-week range spans $1.25 to $5.30. Rallies surfaces VIVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find VIVS SEC filings?

Rallies organizes VIVS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

VIVS Key Metrics

Key financial metrics for VIVS
MetricValue
Price$1.29
Market Cap$3.68M
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$5.30
52-Week Low$1.25
Volume177.55K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest VIVS News

Recent VIVS Insider Trades

  • Gobel David bought 3.27K (~$7.30K) on Nov 17, 2025.

VIVS Analyst Consensus

VIVS analyst coverage data. Average price target: $0.00.

Common questions about VIVS

Where can I find VIVS SEC filings?
Rallies organizes VIVS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show VIVS 10-K and 10-Q filings?
Rallies organizes VIVS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is VIVS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for VIVS. It does not provide personalized investment advice.
VIVS

VIVS